Related Experiment Video
Updated: Apr 5, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Pinta: Latin America's Forgotten Disease?
1Program in Infectious Diseases, Department of Epidemiology, Gillings School of Global Public Health, Hooker Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina lstamm@email.unc.edu.
Pinta, a chronic skin disease caused by Treponema carateum, is re-emerging in Latin America. Early diagnosis and penicillin treatment are crucial for managing this neglected tropical disease.
Area of Science:
- Dermatology
- Infectious Diseases
- Neglected Tropical Diseases
Background:
- Pinta is a chronic, neglected skin disease historically endemic in Latin America.
- The etiological agent, Treponema carateum, is difficult to distinguish from other Treponema pallidum subspecies.
- Current prevalence data is lacking due to insufficient surveillance.
Purpose of the Study:
- To highlight the re-emergence of pinta in Latin America.
- To inform U.S. physicians about pinta's differential diagnosis in migrant populations.
- To emphasize the treatability of pinta.
Main Methods:
- Review of historical and epidemiological data on pinta.
- Comparison of Treponema species using available diagnostic information.
- Clinical and public health recommendations for physicians.
Main Results:
- Pinta remains a concern in formerly endemic regions.
- Treponema carateum's distinctness from other treponemes requires further molecular investigation.
- Pinta is treatable with penicillin.
Conclusions:
- U.S. physicians should consider pinta in the differential diagnosis of skin conditions in children and adolescents from endemic areas.
- Prompt diagnosis and treatment with penicillin are effective for all stages of pinta.
- Improved surveillance is needed to understand the current prevalence of pinta.
Related Concept Videos
Colonisation of Pathogens
Infectious Diseases and Their Occurrence
The Colonization of Land
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Diversity of Protists II

